Tag: services

Bovada has introduced an enhanced welcome bonus that caters to those who want to bet on the NBA Finals and Stanley Cup in line with its commitment to player reward initiatives.

ATHENS, Greece, June 16, 2025 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. (Nasdaq: IMPP) (the “Company”), a ship-owning company providing petroleum products, crude oil, and drybulk seaborne transportation services, today announced a dividend of $0.546875 per share on its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Shares”), payable on June 30, 2025 to holders of record as of June 25, 2025. The dividend payment relates to the period from the last dividend payment date for the Series A Preferred Shares on March 30, 2025, through June 29, 2025.

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today, no later than 11 pm Eastern Time.

LIMASSOL, Cyprus, June 16, 2025 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ:RBNE) ("Robin Energy" or the "Company"), an international ship-owning company providing energy transportation services globally, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 965,000 common shares at an offering price of $5.25, for gross proceeds of approximately $5.1 million (the “Offering”), before deducting commissions and offering expenses, in a registered direct offering priced at-the-market under Nasdaq rules.

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Greystone Real Estate Advisory Group (GREA), a best-in-class commercial real estate management service provider to the public, private, and not-for-profit sectors, announced it has been selected as Transaction Advisor by the Massachusetts Division of Capital Asset Management & Maintenance (DCAMM) to advise the agency on facilitating the development of a new courthouse facility in Springfield, MA.

Les résultats d’études croisées de l’association ibrutinib et vénétoclax en première intention montrent un bénéfice clinique significatif pour une durée fixe, ainsi qu’une probabilité accrue de maladie résiduelle minimale indétectable et de survie sans progression par rapport à l’association acalabrutinib et vénétoclax¹